Animal drugs, feeds, and related products: New drug applications— Bacitracin methylene disalicylate, decoquinate, and roxarsone; correction,

[Federal Register: September 11, 1998 (Volume 63, Number 176)]

[Rules and Regulations]

[Page 48576-48577]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr11se98-8]

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 558

New Animal Drugs For Use In Animal Feeds; Bacitracin Methylene Disalicylate, Decoquinate, and Roxarsone; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule; correction.

SUMMARY: The Food and Drug Administration (FDA) is correcting a final rule that appeared in the Federal Register of July 17, 1998 (63 FR 38474). The document amended the animal drug regulations to reflect approval of a new animal drug application (NADA) filedby Alpharma Inc. The NADA provides for using approved bacitracin methylene disalicylate, decoquinate, and roxarsone Type A medicated articles to make combination drug Type C medicated broiler chicken feeds. The document was published with two typographical errors. This document corrects those errors.

EFFECTIVE DATE: July 17, 1998.

FOR FURTHER INFORMATION CONTACT: Carolyn C. Harris, Office of Policy (HF-27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-443-2994.

In FR Doc. 98-19025, appearing on page 38474 in the Federal Register of Friday, July 17, 1998, the following corrections are made:

1. On page 38475, in the third column, in amendatory instruction ``2.'' the citation ``(d)(3)(xv)'' is corrected to read ``(d)(3)(xvii)''.

   Sec. 558.76 [Corrected]

2. On page 38475, in the third column, in Sec. 558.76 Bacitracin methylene disalicylate, paragraph ``(d)(3)(xv)'' is corrected to read ``(d)(3)(xvii)''.

   [[Page 48577]]

   Dated: August 25, 1998. Stephen F. Sundlof, Director, Center for Veterinary Medicine.

   [FR Doc. 98-24412Filed9-10-98; 8:45 am]

   BILLING CODE 4160-01-F